Myogenes is an advanced molecular diagnostic company centred on personalised health and genetic testing. The company is UK based and situated in London. Our mission is to bring and develop the field of Personalised Medicine in the United Kingdom, focusing on personalised genetic testing. We work jointly with medical doctors, genetic experts and with genetic laboratories located worldwide. Myogenes distributes genetic tests though doctors’ clinics and directly to patients’ homes. We provide full and personal support to our patients and doctors through our professional experts. There is no more ‘one size fits all’. This is personalised medicine, where your body determines what works.
High end clinical
Personal support service
for patients & doctors
The simple PGxOne Plus genetic test allows you to be precise and personal when prescribing medication. By taking this simple test we can be more accurate on choosing the right medicine and the right dose . By applying the results, drugs can be more efficient with less side effects.
Genecept Assay genetic testing can help unlock what your body needs to feel better, faster. Help reduce the time, expense and struggle of finding the right treatment by trial and error. 76% of reporting clinicians elected to make changes to treatment after using the Genecept Assay®.
The NutriFit test ensures we can create a personalised diet and fitness program designed specifically for you. By applying the results, you can create a personalised diet, nutrition and lifestyle plan, sports and fitness programs, based on your individual genetic makeup.
Discover how your DNA can determine your risk for cancer. 98 genes. 25 hereditary cancers. The most comprehensive test on the market. Inherited genetic mutations can increase your cancer risk. Knowing your risk can enable you to manage your health proactively.
Although harmful mutations in BRCA1 and BRCA2 are responsible for the disease in nearly half of families with multiple cases of breast cancer and up to 90 percent of families with both breast and ovarian cancer, mutations in a number of other genes have been associated with increased risks of breast and/or ovarian cancers.
Would you like to know, with greater certainty, which medicines work and which don’t? Which will cause greater side effects and harm and which are safer for use? A simple one time only DNA test will give you the answers you’re looking for…
The Genecept Assay® is a genetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. It identifies patient-specific genetic markers that indicate which treatments are likely to work as intended…
Although harmful mutations in BRCA1 and BRCA2 are responsible for the disease in nearly half of families with multiple cases of breast cancer and up to 90 percent of families with both breast and ovarian cancer, mutations in a number of other genes…